Make an enquiry
Refer a patient
Pay my bill
0808 304 2332

We noticed you are on our UK page. Want to switch regions? Choose from the options:

AU
ES
GenesisCare - logo
Patients
Find a centre
Find a doctor
0808 304 2332
Make an enquiry
Refer a patient
Pay my bill

We noticed you are on our UK page. Want to switch regions? Choose from the options:

AU
ES
Find a centre
Find a doctor
0808 304 2332
Dr Joel Newman
/content/dam/genesiscare/headshots/uk-doctor-headshots/Dr Adam Mead.jpg

Dr Adam Mead

Dr Adam Mead
Adam
Mead
FRCP, FRCPath, PhD, FMedSci, Professor of Haematology

Languages spoken

English

Expert in

Blood cancer diagnosis and treatment, myeloproliferative neoplasms, myelodysplasia, mastocytosis, chronic myeloid leukaemia

Overview

Centre

Oxford

Peters Way, Sandy Lane West, Oxford, Oxfordshire, OX4 6LB, England, UK

Oxford
Peters Way, Sandy Lane West, Oxford, Oxfordshire, OX4 6LB, England, UK
51.7239071200697, -1.2145938932540707
/uk/our-centres/oxford
Oxfordshire
01865 237 700
contactus@genesiscare.co.uk

Specialises in

Blood cancer

Treatments

Haematology

Diagnostics

Blood cancer diagnosis and treatment, myeloproliferative neoplasms, myelodysplasia, mastocytosis, chronic myeloid leukaemia

Professor Adam Mead is a Consultant Haematologist and internationally recognised expert in myeloproliferative neoplasms (MPN) and chronic myeloid leukaemia (CML). Based at Oxford University Hospitals and the University of Oxford, he leads a specialist clinical and research team focused on developing better treatments for patients with blood cancers.

With over 20 years of experience in haematology, Professor Mead has led more than 50 clinical trials and is passionate about bringing cutting-edge science to patient care. His research has helped uncover why some blood cancers become resistant to treatment and how inflammation plays a key role. He is a past chair (2016-2022) of the National Cancer Research Institute myeloproliferative neoplasms clinical study group. Professor Mead has published over 150 research articles and is Editor-in-Chief of Postgraduate Haematology, a 58 chapter textbook aimed at clinical and laboratory haematologists that is widely used internationally.

I chose haematology as a career because it is at the forefront of the application of scientific research towards the provision of tailored, long-term care for patients. I’m passionate about turning discoveries in the lab and clinical trials into real benefits for people

 

 

Expertise and interests

Areas of specialism for Dr Mead include blood cancer diagnosis and treatment, myeloproliferative neoplasms, myelodysplasia, mastocytosis, chronic myeloid leukaemia. 

Other clinical interests include investigation of anaemia, high platelet count, polycythaemia, neutropenia, high white blood cell count

 

Professional memberships

  1. Trustee, British Society of Haematology
  2. Fellow, Royal College of Physicians
  3. Fellow, Royal College of Pathologists
  4. Member, American Society of Hematology
  5. Fellow, Academy of Medical Sciences

 

Publications and Affiliations

Editor-in-Chief, Postgraduate Haematology, 8th Edition
 
Co-author of British Society of Haematology Guidelines for Polycythaemia Vera, Essential Thrombocythaemia, Eosinophilia, Chronic Myeloid Leukaemia, Myelofibrosis
 
Published over 150 peer reviewed research papers and review articles    

Awards Received

NHS National Excellence (2018) and Clinical Impact Award (2023)

Grinberg-Wisch Award, Mount Sinai School of Medicine (2022)

CRUK Senior Cancer Research Fellowship (2019) Fellow of the Academy of Medical Sciences (2024)